BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38431724)

  • 1. Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics.
    Zhong Z; Hou J; Yao Z; Dong L; Liu F; Yue J; Wu T; Zheng J; Ouyang G; Yang C; Song J
    Nat Commun; 2024 Mar; 15(1):1929. PubMed ID: 38431724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics.
    Yang G; Cheng J; Xu J; Shen C; Lu X; He C; Huang J; He M; Cheng J; Wang H
    J Transl Med; 2024 Feb; 22(1):210. PubMed ID: 38414015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial transcriptomics deconvolution at single-cell resolution using Redeconve.
    Zhou Z; Zhong Y; Zhang Z; Ren X
    Nat Commun; 2023 Dec; 14(1):7930. PubMed ID: 38040768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.
    Wang C; He Y; Zheng J; Wang X; Chen S
    Front Immunol; 2023; 14():1130513. PubMed ID: 37153569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell landscape and spatial transcriptomic analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma.
    Wen CY; Hsiao JH; Tzeng YT; Chang R; Tsang YL; Kuo CH; Li CJ
    Aging (Albany NY); 2023 Oct; 15(20):11298-11312. PubMed ID: 37847178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer.
    Li R; Ferdinand JR; Loudon KW; Bowyer GS; Laidlaw S; Muyas F; Mamanova L; Neves JB; Bolt L; Fasouli ES; Lawson ARJ; Young MD; Hooks Y; Oliver TRW; Butler TM; Armitage JN; Aho T; Riddick ACP; Gnanapragasam V; Welsh SJ; Meyer KB; Warren AY; Tran MGB; Stewart GD; Cortés-Ciriano I; Behjati S; Clatworthy MR; Campbell PJ; Teichmann SA; Mitchell TJ
    Cancer Cell; 2022 Dec; 40(12):1583-1599.e10. PubMed ID: 36423636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal gene expression profile reveals the common key signatures associated with clear cell renal cell carcinoma: a meta-analysis.
    Zhang HJ; Sun ZQ; Qian WQ; Sheng L
    Genet Mol Res; 2015 Mar; 14(1):2216-24. PubMed ID: 25867368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of bulk RNA sequencing and scRNA sequencing uncover the molecular characteristics of MAPK signaling in kidney renal clear cell carcinoma.
    Li X; Guan H; Ma C; Dai Y; Su J; Chen X; Yuan Q; Wang J
    Aging (Albany NY); 2024 Jan; 16(2):1414-1439. PubMed ID: 38217548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
    Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY
    Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probabilistic cell/domain-type assignment of spatial transcriptomics data with SpatialAnno.
    Shi X; Yang Y; Ma X; Zhou Y; Guo Z; Wang C; Liu J
    Nucleic Acids Res; 2023 Dec; 51(22):e115. PubMed ID: 37941153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
    Chen L; Xiang Z; Chen X; Zhu X; Peng X
    Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep learning exploration of single-cell and spatially resolved cancer transcriptomics to unravel tumour heterogeneity.
    Halawani R; Buchert M; Chen YP
    Comput Biol Med; 2023 Sep; 164():107274. PubMed ID: 37506451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders.
    Gu T; Zhao X
    Sci Rep; 2019 Nov; 9(1):16668. PubMed ID: 31723226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.